home
portfolio
team
careers
contact
investor portal
home
portfolio
team
careers
contact
investor portal
Nextech Invest
Vividion Therapeutics Announces Oversubscribed $82 Million Series B Financing
Vividion Therapeutics Announces Oversubscribed $82 Million Series B Financing
Post navigation
Previous Post
Previous
IDEAYA Receives Authorization to Proceed with Phase 1/2 Tissue-Type Agnostic Basket Trial to Treat Patients with Tumors Harboring GNAQ/11 Mutations and PKC Fusions
Next Post
Next
Turning Point Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares